title: Incidence of stent under-deployment as a cause of in-stent restenosis in long stents.
abstract: Although stent under-deployment (SU) has been associated with increased risk of in-stent restenosis, little data have been reported on the incidence of SU in patients presenting with clinical in-stent restenosis. In 59 patients referred for vascular brachytherapy and showing angiographic in-stent restenosis, we sought (1) to determine the incidence of SU using standard intravascular ultrasound (IVUS) criteria (2) to evaluate the effects of repeat angioplasty on further stent expansion. Stented length was 32+/-17 mm and diameter stenosis was 75+/-14%. Before re-intervention, the incidence of reduced absolute values of minimal stent cross-sectional area (MSCSA) varied from 69% (< or =8 mm2) to 15% (< or =5 mm2). After re-intervention, the incidence decreased to 24% (< or =8 mm2) (p = 0.0001) and 0% (< or =5 mm2) (p = 0.005). Before re-intervention, SU as assessed by relative criteria varied from 21% (80% mean reference lumen area or 90% minimum distal reference lumen area) to 28% (100% minimum reference lumen area). After re-intervention, the incidence of SU varied from 7% (90% minimum distal reference lumen area) (p = 0.0001 vs. pre) to 24% (55% mean reference EEM area) (p = ns). No change in strut apposition (97% pre vs. 100% post) nor in symmetry index (100% pre vs. post) was noted. From all criteria, the 90 and 100% minimum reference lumen area criteria were the most altered by repeat balloon dilatation, 21% pre vs. 7% post and 28% pre vs. 11% post, respectively. In conclusion, among patients presenting with severe angiographic in-stent restenosis, a significant number showed signs of SU whose incidence varied according to applied criteria. Significant stent re-expansion can be obtained following IVUS-guided repeat angioplasty irrespective of initial SU criteria.
authors.affiliation: Quebec Heart-Lung Institute, Laval Hospital, Quebec City, Canada H1T 1C8.
authors.forename: Olivier F
authors.initials: OF
authors.lastname: Bertrand
authors.forename: Robert
authors.initials: R
authors.lastname: De Larochellière
authors.forename: Michel
authors.initials: M
authors.lastname: Joyal
authors.forename: Raoul
authors.initials: R
authors.lastname: Bonan
authors.forename: Rosaire
authors.initials: R
authors.lastname: Mongrain
authors.forename: Jean-Claude
authors.initials: JC
authors.lastname: Tardif
mesh_terms: D000800:Angioplasty, Balloon; D019917:Blood Vessel Prosthesis Implantation; D001918:Brachytherapy; D003131:Combined Modality Therapy; D017023:Coronary Angiography; D003324:Coronary Artery Disease / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy; D023903:Coronary Restenosis / Q000175:diagnosis / Q000209:etiology*; D020878:Device Removal; D005260:Female; D006801:Humans; D015994:Incidence; D008297:Male; D011792:Quebec / Q000453:epidemiology; D015607:Stents / Q000009:adverse effects*; D017211:Treatment Failure; D018084:Ultrasonography, Interventional